UP-REGULATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) RECEPTORS IN MURINE PERITONEAL-EXUDATE MACROPHAGES BY BOTH GM-CSF AND IL-3

被引:0
|
作者
FAN, K [1 ]
RUAN, QY [1 ]
SENSENBRENNER, L [1 ]
CHEN, BDM [1 ]
机构
[1] WAYNE STATE UNIV, SCH MED,DEPT INTERNAL MED,DIV HEMATOL ONCOL, POB 02188, DETROIT, MI 48202 USA
来源
JOURNAL OF IMMUNOLOGY | 1992年 / 149卷 / 01期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Murine peritoneal exudate macrophages (PEM) display multiple CSF receptors. In this study, the expression of granulocyte-macrophage (GM)-CSF receptors in PEM was studied. PEM displayed over 5000 single type, high affinity GM-CSF receptors/cell with a K(d) = 38 to 42 pM and an apparent molecular mass of 86,000 Da. Treatment of PEM with low, but not high, concentrations of recombinant murine (rMu) GM-CSF continuously for 24 h resulted in a marked up-regulation of GM-CSF receptors in PEM. A similar up-regulation of GM-CSF receptors also was detected in PEM cultures treated with rMuIL-3 (1-100 ng/ml) for 24 h or longer, regardless the doses of rMuIL-3 added in this case. Scatchard analysis of equilibrium binding showed that the enhanced binding activities in both cases were due to an increase in total number of GM-CSF receptors rather than changes in receptor affinity. Contrariwise, treatment with recombinant human macrophage-CSF (> 100-1000 ng/ml) partially inhibited the expression of GM-CSF receptors in PEM. Removal of rMuGM-CSF from culture medium 24 h after treatment led to a further up-regulation of GM-CSF receptors over a 4 to 24-h period, depending on the doses of initial treatment. On the other hand, removal of rMuIL-3 from culture medium after prolonged treatment did not result in further increase in GM-CSF receptors. The protein synthesis inhibitor cycloheximide abrogated GM-CSF receptor upregulation induced by both rMuIL-3 and rMuGM-CSF, whereas actinomycin D inhibited only the second (8-24 h) phase of GM-CSF receptor up-regulation induced by exposure to high concentrations rMuGM-CSF (10 ng/ml). These findings suggest that rMuGM-CSF and rMuIL-3 up-regulate GM-CSF receptors in PEM in part through similar or identical metabolic pathways and provide further evidence of a close linkage between IL-3 and GM-CSF receptors.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 50 条
  • [1] IN-VIVO EFFECT OF HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) ON NEUTROPHIL GM-CSF RECEPTORS
    STACCHINI, A
    FUBINI, L
    GATTI, E
    MUTTI, L
    PIACIBELLO, W
    SANAVIO, F
    SCAGLIOTTI, G
    POZZI, E
    AGLIETTA, M
    LEUKEMIA, 1995, 9 (04) : 665 - 670
  • [2] FUTURE USES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF)
    JONES, TC
    STEM CELLS, 1994, 12 : 229 - 240
  • [4] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF), HYPOCALCEMIA, AND HYPOMAGNESEMIA
    POTTER, MN
    MOTT, MG
    OAKHILL, A
    ANNALS OF INTERNAL MEDICINE, 1990, 112 (09) : 715 - 715
  • [5] Granulocyte-macrophage colony stimulating factor (GM-CSF) in malignancy
    van Pelt, J
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1998, 15 (05) : 473 - 473
  • [6] Characterization of the function and expression of the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor with a novel GM-CSF fusion protein
    Rosas, M
    Gordon, S
    Taylor, PR
    JOURNAL OF LEUKOCYTE BIOLOGY, 2005, : 28 - 28
  • [7] Immunogenicity of granulocyte-macrophage colony-stimulating factor (GM-CSF) products in patients undergoing combination therapy with GM-CSF
    Wadhwa, M
    Skog, ALH
    Bird, C
    Ragnhammar, P
    Lilljefors, M
    Gaines-Das, R
    Mellstedt, H
    Thorpe, R
    CLINICAL CANCER RESEARCH, 1999, 5 (06) : 1353 - 1361
  • [8] REGULATION OF ENDOMETRIAL GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) PRODUCTION IN THE EWE
    TAMURA, K
    HARBISON, LA
    CHRISTENSON, RK
    IMAKAWA, K
    BIOLOGY OF REPRODUCTION, 1995, 52 : 154 - 154
  • [9] Antibody Against Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) and Inhaled GM-CSF for Pulmonary Alveolar Proteinosis
    Tazawa, R.
    Ueda, T.
    Abe, M.
    Tatsumi, K.
    Eda, R.
    Kondoh, S.
    Morimoto, K.
    Tanaka, T.
    Yamaguchi, E.
    Takahashi, A.
    Oda, M.
    Ishii, H.
    Izumi, S.
    Sugiyama, H.
    Nakagawa, A.
    Tomii, K.
    Suzuki, M.
    Konno, S.
    Ohkouchi, S.
    Tode, N.
    Handa, T.
    Hirai, T.
    Inoue, Y.
    Arai, T.
    Asakawa, K.
    Sakagami, T.
    Hashimoto, A.
    Tanaka, T.
    Takada, T.
    Mikami, A.
    Kitamura, N.
    Nakata, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [10] IS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) SAFE IN MYELODYSPLASTIC SYNDROMES
    MITTELMAN, M
    FLORU, S
    PICK, AI
    HAEMATOLOGIA, 1994, 26 (02) : 111 - 115